Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Liver Diseases

Free Subscription 11.03.2019 2 Am J Gastroenterol 3 Anticancer Res 3 Biochem Biophys Res Commun 5 Br J Surg 1 Cancer Res 7 Dig Dis Sci 4 Gastroenterology 5 Hepatology 1 Int J Cancer 3 J Gastroenterol 2 J Gastroenterol Hepatol 1 J Hepatol 7 J Pediatr 1 J Pediatr Surg 2 Lancet Diabetes Endocrinol 1 Lancet Infect Dis 8 Oncogene 2 PLoS Genet 10 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Gastroenterol

1. LABENZ C, Toenges G, Huber Y, Nagel M, et al
   Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
   Am J Gastroenterol. 2019 Feb 18. doi: 10.14309/ajg.0000000000000121.
   PubMed     Text format     Abstract available
   
   
2. OGIWARA S, Furihata M, Fukami K, Yamashita A, et al
   Hepatoid Adenocarcinoma With Enteroblastic Differentiation in the Sigmoid Colon: Lessons From a Rare Case.
   Am J Gastroenterol. 2019 Feb 26. doi: 10.14309/ajg.0000000000000176.
   PubMed     Text format    
   
   

   
   Anticancer Res

3. 
   Hepatic Stem Cells.
   Anticancer Res. 2019;39:1631.
   PubMed     Text format    
   
   
4. SCHNAPAUFF D, Tegel BR, Powerski MJ, Colletini F, et al
   Interstitial Brachytherapy in Combination With Previous Transarterial Embolization in Patients With Unresectable Hepatocellular Carcinoma.
   Anticancer Res. 2019;39:1329-1336.
   PubMed     Text format     Abstract available
   
   
5. XU X, Gao D, Yuan X, Liu LI, et al
   beta-Catenin Expression Correlates With Prognosis in Hepatocellular Carcinoma Patients Treated With Transcatheter Arterial Chemoembolization.
   Anticancer Res. 2019;39:1129-1134.
   PubMed     Text format     Abstract available
   
   

   
   Biochem Biophys Res Commun

6. KIM MK, Kim MA, Yim JH, Lee DH, et al
   Ramalin, an antioxidant compound derived from Antarctic lichen, prevents progression of liver fibrosis induced by dimethylnitrosamine (DNM) in rats.
   Biochem Biophys Res Commun. 2018;504:25-33.
   PubMed     Text format     Abstract available
   
   
7. TSUGAWA Y, Hiramoto M, Imai T
   Estrogen induces estrogen receptor alpha expression and hepatocyte proliferation in late pregnancy.
   Biochem Biophys Res Commun. 2019 Feb 27. pii: S0006-291X(19)30320.
   PubMed     Text format     Abstract available
   
   
8. HIGASHI M, Yoneda M, Nakagawa T, Ikeda M, et al
   miR-222 regulates proliferation of primary mouse hepatocytes in vitro.
   Biochem Biophys Res Commun. 2019 Feb 27. pii: S0006-291X(19)30289.
   PubMed     Text format     Abstract available
   
   

   
   Br J Surg

9. MARGONIS GA, Sasaki K, Gholami S, Kim Y, et al
   Genetic And Morphological Evaluation (GAME) score for patients with colorectal liver metastases.
   Br J Surg. 2018;105:1210-1220.
   PubMed     Text format     Abstract available
   
   
10. OKUNO M, Goumard C, Mizuno T, Kopetz S, et al
    Prognostic impact of perihepatic lymph node metastases in patients with resectable colorectal liver metastases.
    Br J Surg. 2018;105:1200-1209.
    PubMed     Text format     Abstract available
    
    
11. SATO N, Kenjo A, Kimura T, Okada R, et al
    Prediction of major complications after hepatectomy using liver stiffness values determined by magnetic resonance elastography.
    Br J Surg. 2018;105:1192-1199.
    PubMed     Text format     Abstract available
    
    
12. MEHRABI A, Golriz M, Khajeh E, Ghamarnejad O, et al
    Meta-analysis of the prognostic role of perioperative platelet count in posthepatectomy liver failure and mortality.
    Br J Surg. 2018;105:1254-1261.
    PubMed     Text format     Abstract available
    
    
13. HALLS MC, Berardi G, Cipriani F, Barkhatov L, et al
    Development and validation of a difficulty score to predict intraoperative complications during laparoscopic liver resection.
    Br J Surg. 2018;105:1182-1191.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

14. FEKIR K, Dubois-Pot-Schneider H, Desert R, Daniel Y, et al
    Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance.
    Cancer Res. 2019 Mar 5. pii: 0008-5472.CAN-18-2110.
    PubMed     Text format     Abstract available
    
    

    
    Dig Dis Sci

15. RONOT M, Purcell Y, Vilgrain V
    Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05547.
    PubMed     Text format     Abstract available
    
    
16. MA L, Ishigami M, Honda T, Yokoyama S, et al
    Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05560.
    PubMed     Text format     Abstract available
    
    
17. ROUT G, Sharma S, Gunjan D, Kedia S, et al
    Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05557.
    PubMed     Text format     Abstract available
    
    
18. SAYINER M, Golabi P, Younossi ZM
    Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05537.
    PubMed     Text format     Abstract available
    
    
19. HARDING JJ, Khalil DN, Abou-Alfa GK
    Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05517.
    PubMed     Text format     Abstract available
    
    
20. REICHMAN TW, Bhati CS, Battula NR
    Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer.
    Dig Dis Sci. 2019 Mar 6. pii: 10.1007/s10620-019-05550.
    PubMed     Text format     Abstract available
    
    
21. KHAN RS, Newsome PN
    Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus?
    Dig Dis Sci. 2019 Mar 7. pii: 10.1007/s10620-019-05573.
    PubMed     Text format    
    
    

    
    Gastroenterology

22. RAVINDRANATH A, Sarma MS, Yachha SK
    An elusive diagnosis in a child with fever and hepatomegaly.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32492.
    PubMed     Text format    
    
    
23. CHEN CY, Wang YP, Lu CL
    An Unusual Hepatic Mass in a Young Man.
    Gastroenterology. 2019 Feb 27. pii: S0016-5085(19)32489.
    PubMed     Text format    
    
    
24. ARROYO V
    Acute-On-Chronic Liver Failure in Cirrhosis Requires Expedited Decision for Liver Transplantation.
    Gastroenterology. 2019 Mar 5. pii: S0016-5085(19)32514.
    PubMed     Text format    
    
    
25. WEINBERG EM
    What Did We Learn From the ADAPT Trials?
    Gastroenterology. 2019;156:824-825.
    PubMed     Text format    
    
    

    
    Hepatology

26. BAJAJ JS, Moreau R, Kamath PS, Vargas HE, et al
    Acute-on-Chronic Liver Failure: Getting Ready for Prime Time?
    Hepatology. 2018;68:1621-1632.
    PubMed     Text format     Abstract available
    
    
27. TRICO D, Caprio S, Rosaria Umano G, Pierpont B, et al
    Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort.
    Hepatology. 2018;68:1376-1390.
    PubMed     Text format     Abstract available
    
    
28. GRAHAM RP, Lackner C, Terracciano L, Gonzalez-Cantu Y, et al
    Fibrolamellar carcinoma in the Carney complex: PRKAR1A loss instead of the classic DNAJB1-PRKACA fusion.
    Hepatology. 2018;68:1441-1447.
    PubMed     Text format     Abstract available
    
    
29. SALEM R, Gabr A, Riaz A, Mora R, et al
    Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
    Hepatology. 2018;68:1429-1440.
    PubMed     Text format     Abstract available
    
    
30. MA M, Xu H, Liu G, Wu J, et al
    MITA1, a novel energy stress-inducible lncRNA, promotes hepatocellular carcinoma metastasis.
    Hepatology. 2019 Mar 6. doi: 10.1002/hep.30602.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

31. TAN HW, Leung CO, Chan KK, Ho DW, et al
    Deregulated GATA6 modulates stem cell-like properties and metabolic phenotype in hepatocellular carcinoma.
    Int J Cancer. 2019 Mar 4. doi: 10.1002/ijc.32248.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol

32. KADO A, Tsutsumi T, Enooku K, Fujinaga H, et al
    Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.
    J Gastroenterol. 2019 Mar 4. pii: 10.1007/s00535-019-01565.
    PubMed     Text format     Abstract available
    
    
33. NAKAHARA T, Hyogo H, Ono A, Nagaoki Y, et al
    Involvement of Porphyromonas gingivalis in the progression of non-alcoholic fatty liver disease.
    J Gastroenterol. 2018;53:269-280.
    PubMed     Text format     Abstract available
    
    
34. YONEDA M, Imajo K, Takahashi H, Ogawa Y, et al
    Clinical strategy of diagnosing and following patients with nonalcoholic fatty liver disease based on invasive and noninvasive methods.
    J Gastroenterol. 2018;53:181-196.
    PubMed     Text format     Abstract available
    
    

    
    J Gastroenterol Hepatol

35. ROSSI UG, Rutigliani M, DeCensi A
    Hepatobiliary and Pancreatic: Sub-Glisson's capsule hepatic multiple nodular formations.
    J Gastroenterol Hepatol. 2019 Mar 4. doi: 10.1111/jgh.14618.
    PubMed     Text format    
    
    
36. YAMATO M, Sakai Y, Mochida H, Kawaguchi K, et al
    Adipose tissue-derived stem cells prevent fibrosis in murine steatohepatitis by suppressing IL-17-mediated inflammation.
    J Gastroenterol Hepatol. 2019 Mar 3. doi: 10.1111/jgh.14647.
    PubMed     Text format     Abstract available
    
    

    
    J Hepatol

37. FRANCOZ C, Sola E
    Assessment of renal function in cirrhosis: Sarcopenia, gender and ethnicity matter.
    J Hepatol. 2019 Mar 1. pii: S0168-8278(19)30118.
    PubMed     Text format    
    
    

    
    J Pediatr

38. TAYLOR SA, Kelly S, Alonso EM, Whitington PF, et al
    The Effects of Gestational Alloimmune Liver Disease on Fetal and Infant Morbidity and Mortality.
    J Pediatr. 2018 Feb 27. pii: S0022-3476(17)31749.
    PubMed     Text format     Abstract available
    
    
39. COLOMBA C, La Placa S, Saporito L, Corsello G, et al
    Intestinal Involvement in Kawasaki Disease.
    J Pediatr. 2018;202:186-193.
    PubMed     Text format     Abstract available
    
    
40. MOUZAKI M, Trout AT, Arce-Clachar AC, Bramlage K, et al
    Assessment of Nonalcoholic Fatty Liver Disease Progression in Children Using Magnetic Resonance Imaging.
    J Pediatr. 2018;201:86-92.
    PubMed     Text format     Abstract available
    
    
41. LALA SM, Naik H, Balwani M
    Diagnostic Delay in Erythropoietic Protoporphyria.
    J Pediatr. 2018;202:320-323.
    PubMed     Text format     Abstract available
    
    
42. MATARAZZO L, Mazzocco M, Gioachin A, Tagliati S, et al
    Wandering Liver, Wondering Doctors!
    J Pediatr. 2018;202:326.
    PubMed     Text format    
    
    
43. MOGUL DB, Luo X, Bowring MG, Chow EK, et al
    Fifteen-Year Trends in Pediatric Liver Transplants: Split, Whole Deceased, and Living Donor Grafts.
    J Pediatr. 2018 Jan 4. pii: S0022-3476(17)31508.
    PubMed     Text format     Abstract available
    
    
44. SORENSEN LG, Neighbors K, Hardison RM, Loomes KM, et al
    Health Related Quality of Life and Neurocognitive Outcomes in the First Year after Pediatric Acute Liver Failure.
    J Pediatr. 2018;196:129-138.
    PubMed     Text format     Abstract available
    
    

    
    J Pediatr Surg

45. YEH YT, Lin NC, Yeh YC, Tsai HL, et al
    Vitamin A can ameliorate fibrosis of liver in an established rat model of biliary atresia and Kasai portoenterostomy.
    J Pediatr Surg. 2018 Sep 7. pii: S0022-3468(18)30539.
    PubMed     Text format     Abstract available
    
    

    
    Lancet Diabetes Endocrinol

46. LI X, Chen L
    Non-alcoholic fatty liver disease concerns with glucokinase activators - Authors' reply.
    Lancet Diabetes Endocrinol. 2018;6:685.
    PubMed     Text format    
    
    
47. HODSON L, Brouwers MCGJ
    Non-alcoholic fatty liver disease concerns with glucokinase activators.
    Lancet Diabetes Endocrinol. 2018;6:684-685.
    PubMed     Text format    
    
    

    
    Lancet Infect Dis

48. VAILLANT A
    Should alanine aminotransferase flares mean stopping antiviral therapy in patients with cirrhosis?
    Lancet Infect Dis. 2019;19:221-222.
    PubMed     Text format    
    
    

    
    Oncogene

49. WANG Y, Xie BH, Lin WH, Huang YH, et al
    Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
    Oncogene. 2019 Mar 6. pii: 10.1038/s41388-019-0766.
    PubMed     Text format     Abstract available
    
    
50. MA D, Chen X, Zhang PY, Zhang H, et al
    Upregulation of the ALDOA/DNA-PK/p53 pathway by dietary restriction suppresses tumor growth.
    Oncogene. 2018;37:1041-1048.
    PubMed     Text format     Abstract available
    
    
51. YANG JB, Zhao ZB, Liu QZ, Hu TD, et al
    FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Oncogene. 2018;37:1192-1204.
    PubMed     Text format     Abstract available
    
    
52. IM JY, Kim BK, Lee JY, Park SH, et al
    DDIAS suppresses TRAIL-mediated apoptosis by inhibiting DISC formation and destabilizing caspase-8 in cancer cells.
    Oncogene. 2018;37:1251-1262.
    PubMed     Text format     Abstract available
    
    
53. BLOMME A, Van Simaeys G, Doumont G, Costanza B, et al
    Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases.
    Oncogene. 2017 Dec 15. pii: 10.1038/s41388-017-0018.
    PubMed     Text format     Abstract available
    
    
54. CHEN Z, Gao Y, Yao L, Liu Y, et al
    LncFZD6 initiates Wnt/beta-catenin and liver TIC self-renewal through BRG1-mediated FZD6 transcriptional activation.
    Oncogene. 2018;37:3098-3112.
    PubMed     Text format     Abstract available
    
    
55. LIU X, Bi L, Wang Q, Wen M, et al
    miR-1204 targets VDR to promotes epithelial-mesenchymal transition and metastasis in breast cancer.
    Oncogene. 2018 Mar 20. pii: 10.1038/s41388-018-0215.
    PubMed     Text format     Abstract available
    
    
56. CHU PC, Lin PC, Wu HY, Lin KT, et al
    Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathway.
    Oncogene. 2018 Mar 21. pii: 10.1038/s41388-018-0222.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Genet

57. DARLAY R, Ayers KL, Mells GF, Hall LS, et al
    Amino acid residues in five separate HLA genes can explain most of the known associations between the MHC and primary biliary cholangitis.
    PLoS Genet. 2018;14:e1007833.
    PubMed     Text format     Abstract available
    
    
58. WILK G, Braun R
    regQTLs: Single nucleotide polymorphisms that modulate microRNA regulation of gene expression in tumors.
    PLoS Genet. 2018;14:e1007837.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

59. LEE CH, Hung SP, Hong JH, Chang JT, et al
    How small is TOO small? New liver constraint is needed- Proton therapy of hepatocellular carcinoma patients with small normal liver.
    PLoS One. 2018;13:e0203854.
    PubMed     Text format     Abstract available
    
    
60. ROMUALDO GR, Prata GB, da Silva TC, Fernandes AAH, et al
    Fibrosis-associated hepatocarcinogenesis revisited: Establishing standard medium-term chemically-induced male and female models.
    PLoS One. 2018;13:e0203879.
    PubMed     Text format     Abstract available
    
    
61. THISTLE JE, Yang B, Petrick JL, Fan JH, et al
    Association of tooth loss with liver cancer incidence and chronic liver disease mortality in a rural Chinese population.
    PLoS One. 2018;13:e0203926.
    PubMed     Text format     Abstract available
    
    
62. CHOI YR, Chung JW, Yu MH, Lee M, et al
    Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    PLoS One. 2018;13:e0203940.
    PubMed     Text format     Abstract available
    
    
63. DILLARD KJ, Hytonen MK, Fischer D, Tanhuanpaa K, et al
    A splice site variant in INPP5E causes diffuse cystic renal dysplasia and hepatic fibrosis in dogs.
    PLoS One. 2018;13:e0204073.
    PubMed     Text format     Abstract available
    
    
64. WARNER DR, Liu H, Ghosh Dastidar S, Warner JB, et al
    Ethanol and unsaturated dietary fat induce unique patterns of hepatic omega-6 and omega-3 PUFA oxylipins in a mouse model of alcoholic liver disease.
    PLoS One. 2018;13:e0204119.
    PubMed     Text format     Abstract available
    
    
65. MIRZADEH A, Yoosefy A, Kazemirad E, Barati Z, et al
    Evaluation of a set of refolded recombinant antigens for serodiagnosis of human fascioliasis.
    PLoS One. 2018;13:e0203490.
    PubMed     Text format     Abstract available
    
    
66. DE BARI B, Breuneval T, Zeverino M, Godin S, et al
    Hepatobiliary scintigraphy allows the evaluation of short-term functional toxicity of liver stereotactic body radiotherapy: Results of a pilot study.
    PLoS One. 2018;13:e0204013.
    PubMed     Text format     Abstract available
    
    
67. WANG Z, Wang J, Wang P
    The prognostic value of prognostic nutritional index in hepatocellular carcinoma patients: A meta-analysis of observational studies.
    PLoS One. 2018;13:e0202987.
    PubMed     Text format     Abstract available
    
    
68. MCCOWAN C, Crameri S, Kocak A, Shan S, et al
    A novel group A rotavirus associated with acute illness and hepatic necrosis in pigeons (Columba livia), in Australia.
    PLoS One. 2018;13:e0203853.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: